Deep Track Capital
Investor profile
Venture capital
Deals
4
distinct rounds
Companies
4
backed
Active span
2021–2025
5 yrs
Total round €
€1.1B
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Invus2
- RA Capital Management2
- Access Biotechnology1
- Andera Partners1
- Ascenta Capital1
- Avidity Partners1
- Avoro Capital Advisors1
- Bayern Kapital1
- CaaS Capital Management1
- EcoR1 Capital1
- EQT Life Sciences1
- Fairmount1
- Forbion1
- Frazier Life Sciences1
- FundPlus1
- HealthCap1
- High-Tech Gründerfonds (HTGF)1
- Maj Invest Equity1
- Nextech Invest1
- Novo Holdings1
- OCCIDENT1
- Omega Funds1
- Perceptive Advisors1
- Piper Heartland Healthcare Capital1
- Rock Springs Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Bicycle Therapeutics | UK | 1 | €513M |
| Tubulis Technologies | Germany | 1 | €308M |
| Artios | UK | 1 | €129M |
| Hemab Therapeutics | Denmark | 1 | €127M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Bicycle Therapeutics | Other | €513M | 2024-05 |
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Artios | Series C | €129M | 2021-07 |
| Hemab Therapeutics | Series B | €127M | 2023-02 |